Goldman Sachs BDC Sees Share Value Slide for Seven Straight Quarters
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 25 2025
0mins
Should l Buy GS?
Goldman Sachs' (GS) business development company, Goldman Sachs BDC (GSBD), has seen its per share value slide for seven straight quarters due to souring loans, AnnaMaria Andriotis of Wall Street Journal reports. The paper notes that BDC's total assets are about $3.4B of the $162B that Goldman's private-credit business manages. Goldman executives looked into BDC's portfolio and told colleagues that the loans had underwriting issues, according to former Goldman private-credit employees, reports Andriotis.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy GS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on GS
Wall Street analysts forecast GS stock price to rise
12 Analyst Rating
5 Buy
7 Hold
0 Sell
Moderate Buy
Current: 807.600
Low
604.00
Averages
951.45
High
1100
Current: 807.600
Low
604.00
Averages
951.45
High
1100
About GS
The Goldman Sachs Group, Inc. is a global financial institution that delivers a range of financial services to a large and diversified client base that includes corporations, financial institutions, governments and individuals. Its segments include Global Banking & Markets, Asset & Wealth Management and Platform Solutions. The Global Banking & Markets segment offers a range of services, including financing, advisory services, risk distribution, and hedging for its institutional and corporate clients. It facilitates client transactions and makes markets in fixed income, equity, currency and commodity products. The Asset & Wealth Management segment manages assets and offers investment products across all asset classes to a diverse set of clients. It also provides investing and wealth advisory solutions. The Platform Solutions segment includes consumer platforms, such as partnerships offering credit cards and point-of-sale financing, and transaction banking and other platform businesses.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Nike Shares Drop 10% Despite Beating Earnings Expectations
- Nike's Revenue Decline: Nike's North American revenue of $5.03 billion fell short of the $5.04 billion expected by analysts, leading to a 10% drop in stock price; however, the company reported fiscal third-quarter earnings of 35 cents per share and $11.28 billion in revenue, exceeding expectations of 28 cents and $11.24 billion, showcasing resilience amid challenges.
- Dave & Buster's Positive Outlook: Dave & Buster's shares rose 7% as management anticipates increases in same-store sales, revenue, and adjusted EBITDA in 2026, despite posting a fourth-quarter adjusted loss of 35 cents per share and revenue of $529.6 million, below the expected profit of 39 cents and revenue of $555.9 million, indicating future growth potential.
- PVH Strong Performance: PVH's stock increased by 1% after reporting fourth-quarter adjusted earnings of $3.82 per share and revenue of $2.51 billion, both surpassing analyst expectations of $3.31 per share and $2.43 billion, reflecting successful brand management.
- NCino Stock Surge: NCino shares surged 22% after providing first-quarter revenue guidance of $154.5 million to $156.4 million, exceeding the $152.7 million consensus, with fourth-quarter revenue also surpassing expectations at $149.7 million, indicating strong performance in the cloud software market.
See More
Trump Signs Executive Order Amid Iran Conflict Hopes
- Market Rally: Wall Street experienced a significant rally on Tuesday due to renewed optimism regarding a potential resolution to the U.S.-Iran conflict, with all three major indexes posting their best day since May; the Dow surged over 1,100 points, the S&P 500 rose 2.91% to 6,528.52, and the Nasdaq Composite climbed 3.83% to 21,590.63, indicating strong investor sentiment.
- Trump's Upcoming Address: The White House announced that President Trump will deliver an important address regarding Iran on Wednesday at 9 p.m. ET, which is expected to further influence market sentiment, especially as he indicated that U.S. military forces might leave Iran in “two to three weeks,” potentially sustaining the current optimism.
- Oil Price Fluctuations: Brent crude prices remained elevated following Iran's attack on a Kuwaiti oil tanker near Dubai, with partial closures of the Strait of Hormuz impacting global supply chains, particularly in the oil sector, highlighting the ongoing geopolitical risks affecting energy markets.
- Tech Stock Movements: OpenAI announced it closed a record-breaking funding round, valuing the company at $852 billion with $122 billion in committed capital, reflecting strong investor interest in the AI sector, while Oracle began layoffs in response to plummeting stock prices, illustrating the uncertainty within the tech industry amid current market conditions.
See More
Market Reaction: Anticipation of U.S.-Iran War Ending
- Market Rally: The S&P 500 and Nasdaq Composite surged by 2.91% and 3.83%, respectively, amid hopes for an end to the U.S.-Iran conflict, indicating potential for future economic recovery as investors anticipate peace.
- Interest Rate Decline: With the war's conclusion, the yield on the 10-year Treasury is expected to drop significantly, which will lower borrowing costs and alleviate inflationary pressures stemming from rising fertilizer and energy prices due to the conflict.
- Growth Stock Resurgence: High-growth stocks like Nvidia and Marvell saw gains of 5.5% and nearly 13%, respectively, suggesting that investors will refocus on these companies' fundamentals without the distraction of geopolitical tensions.
- Big Bank Stocks Rally: The end of the war is likely to revive trading activity on Wall Street, with major financial stocks like Goldman Sachs and Morgan Stanley rising nearly 5% and 4%, respectively, reflecting optimism about future merger and acquisition activities.
See More
Wall Street Ends Month on High Note Amid Optimism
- Market Rally: By 1:30 PM ET, the Dow Jones Industrial Average rose by 2.1%, the S&P 500 increased by 2.4%, and the Nasdaq Composite surged by 3.6%, reflecting a renewed optimism among investors regarding market sentiment.
- Stable Fed Policy: Fed Chair Jerome Powell's remarks did not incite panic, leading investors to interpret that the Fed is unlikely to implement drastic rate hikes, thereby alleviating inflation concerns and contributing to the stock market's rise.
- Geopolitical Influence: President Trump's discussion of a potential end to the Iran conflict provided a boost to market optimism; while oil prices remain high, the anticipation of de-escalation in tensions has sparked a rally in the stock market.
- Strong Individual Stock Performance: Goldman Sachs and Caterpillar both saw gains of around 5%, while Nvidia's announcement of a $2 billion investment in Marvell Technology led to a 12% surge in Marvell's shares, highlighting the potential of AI infrastructure investments despite limited impact on major market indexes.
See More
Fed Chair Powell's Remarks Ease Market Fears Amid Rally
- Fed Policy Stability: Fed Chair Jerome Powell's remarks did not terrify the market, as investors interpreted them as a sign that the Fed is unlikely to take aggressive rate actions, alleviating inflation concerns and boosting market sentiment.
- Iran Situation Easing: Reports of President Trump's discussions about potentially ending the Iran conflict provided optimism to investors; while oil prices remain near multi-year highs, the hint of de-escalation sparked a rally in the stock market.
- Major Index Performance: By 1:30 PM ET, the S&P 500 had risen 2.4%, the Dow Jones Industrial Average was up 2.1%, and the Nasdaq Composite surged 3.6%, indicating a strong market rebound, although all indexes are still on track for their worst month in several years.
- Investor Strategy Adjustment: Despite increased market volatility, long-term investors may view the current fluctuations as an opportunity to add quality positions at lower valuations, emphasizing the importance of maintaining a diversified investment strategy.
See More
Goldman Sachs Optimistic on Nvidia's AI Healthcare Prospects
- Positive Market Outlook: Goldman Sachs' buy rating on Nvidia and a $250 price target imply a 51% upside, reflecting investor confidence in its AI applications within healthcare and life sciences.
- Collaborative Technological Edge: By partnering with life sciences companies, Nvidia can validate its models in labs, leveraging digital twins and simulation to enhance the quality of experiments and manufacturing while reducing costs, thereby strengthening its market position.
- Investment and Applications: In 2023, Nvidia invested $50 million in clinical-stage biotech firm Recursion Pharmaceuticals to develop AI models for accelerating drug discovery, driving technological advancements in the biopharma sector.
- Clinical Trial Efficiency Gains: Recursion's AI technology enables drugmakers to synthesize 90% fewer compounds and reduces the average time to enter human trials from 42 months to 17 months, significantly improving research and development efficiency.
See More
Nike Shares Drop 10% Despite Beating Earnings Expectations
- Nike's Revenue Decline: Nike's North American revenue of $5.03 billion fell short of the $5.04 billion expected by analysts, leading to a 10% drop in stock price; however, the company reported fiscal third-quarter earnings of 35 cents per share and $11.28 billion in revenue, exceeding expectations of 28 cents and $11.24 billion, showcasing resilience amid challenges.
- Dave & Buster's Positive Outlook: Dave & Buster's shares rose 7% as management anticipates increases in same-store sales, revenue, and adjusted EBITDA in 2026, despite posting a fourth-quarter adjusted loss of 35 cents per share and revenue of $529.6 million, below the expected profit of 39 cents and revenue of $555.9 million, indicating future growth potential.
- PVH Strong Performance: PVH's stock increased by 1% after reporting fourth-quarter adjusted earnings of $3.82 per share and revenue of $2.51 billion, both surpassing analyst expectations of $3.31 per share and $2.43 billion, reflecting successful brand management.
- NCino Stock Surge: NCino shares surged 22% after providing first-quarter revenue guidance of $154.5 million to $156.4 million, exceeding the $152.7 million consensus, with fourth-quarter revenue also surpassing expectations at $149.7 million, indicating strong performance in the cloud software market.
See More
Trump Signs Executive Order Amid Iran Conflict Hopes
- Market Rally: Wall Street experienced a significant rally on Tuesday due to renewed optimism regarding a potential resolution to the U.S.-Iran conflict, with all three major indexes posting their best day since May; the Dow surged over 1,100 points, the S&P 500 rose 2.91% to 6,528.52, and the Nasdaq Composite climbed 3.83% to 21,590.63, indicating strong investor sentiment.
- Trump's Upcoming Address: The White House announced that President Trump will deliver an important address regarding Iran on Wednesday at 9 p.m. ET, which is expected to further influence market sentiment, especially as he indicated that U.S. military forces might leave Iran in “two to three weeks,” potentially sustaining the current optimism.
- Oil Price Fluctuations: Brent crude prices remained elevated following Iran's attack on a Kuwaiti oil tanker near Dubai, with partial closures of the Strait of Hormuz impacting global supply chains, particularly in the oil sector, highlighting the ongoing geopolitical risks affecting energy markets.
- Tech Stock Movements: OpenAI announced it closed a record-breaking funding round, valuing the company at $852 billion with $122 billion in committed capital, reflecting strong investor interest in the AI sector, while Oracle began layoffs in response to plummeting stock prices, illustrating the uncertainty within the tech industry amid current market conditions.
See More
Market Reaction: Anticipation of U.S.-Iran War Ending
- Market Rally: The S&P 500 and Nasdaq Composite surged by 2.91% and 3.83%, respectively, amid hopes for an end to the U.S.-Iran conflict, indicating potential for future economic recovery as investors anticipate peace.
- Interest Rate Decline: With the war's conclusion, the yield on the 10-year Treasury is expected to drop significantly, which will lower borrowing costs and alleviate inflationary pressures stemming from rising fertilizer and energy prices due to the conflict.
- Growth Stock Resurgence: High-growth stocks like Nvidia and Marvell saw gains of 5.5% and nearly 13%, respectively, suggesting that investors will refocus on these companies' fundamentals without the distraction of geopolitical tensions.
- Big Bank Stocks Rally: The end of the war is likely to revive trading activity on Wall Street, with major financial stocks like Goldman Sachs and Morgan Stanley rising nearly 5% and 4%, respectively, reflecting optimism about future merger and acquisition activities.
See More
Wall Street Ends Month on High Note Amid Optimism
- Market Rally: By 1:30 PM ET, the Dow Jones Industrial Average rose by 2.1%, the S&P 500 increased by 2.4%, and the Nasdaq Composite surged by 3.6%, reflecting a renewed optimism among investors regarding market sentiment.
- Stable Fed Policy: Fed Chair Jerome Powell's remarks did not incite panic, leading investors to interpret that the Fed is unlikely to implement drastic rate hikes, thereby alleviating inflation concerns and contributing to the stock market's rise.
- Geopolitical Influence: President Trump's discussion of a potential end to the Iran conflict provided a boost to market optimism; while oil prices remain high, the anticipation of de-escalation in tensions has sparked a rally in the stock market.
- Strong Individual Stock Performance: Goldman Sachs and Caterpillar both saw gains of around 5%, while Nvidia's announcement of a $2 billion investment in Marvell Technology led to a 12% surge in Marvell's shares, highlighting the potential of AI infrastructure investments despite limited impact on major market indexes.
See More
Fed Chair Powell's Remarks Ease Market Fears Amid Rally
- Fed Policy Stability: Fed Chair Jerome Powell's remarks did not terrify the market, as investors interpreted them as a sign that the Fed is unlikely to take aggressive rate actions, alleviating inflation concerns and boosting market sentiment.
- Iran Situation Easing: Reports of President Trump's discussions about potentially ending the Iran conflict provided optimism to investors; while oil prices remain near multi-year highs, the hint of de-escalation sparked a rally in the stock market.
- Major Index Performance: By 1:30 PM ET, the S&P 500 had risen 2.4%, the Dow Jones Industrial Average was up 2.1%, and the Nasdaq Composite surged 3.6%, indicating a strong market rebound, although all indexes are still on track for their worst month in several years.
- Investor Strategy Adjustment: Despite increased market volatility, long-term investors may view the current fluctuations as an opportunity to add quality positions at lower valuations, emphasizing the importance of maintaining a diversified investment strategy.
See More
Goldman Sachs Optimistic on Nvidia's AI Healthcare Prospects
- Positive Market Outlook: Goldman Sachs' buy rating on Nvidia and a $250 price target imply a 51% upside, reflecting investor confidence in its AI applications within healthcare and life sciences.
- Collaborative Technological Edge: By partnering with life sciences companies, Nvidia can validate its models in labs, leveraging digital twins and simulation to enhance the quality of experiments and manufacturing while reducing costs, thereby strengthening its market position.
- Investment and Applications: In 2023, Nvidia invested $50 million in clinical-stage biotech firm Recursion Pharmaceuticals to develop AI models for accelerating drug discovery, driving technological advancements in the biopharma sector.
- Clinical Trial Efficiency Gains: Recursion's AI technology enables drugmakers to synthesize 90% fewer compounds and reduces the average time to enter human trials from 42 months to 17 months, significantly improving research and development efficiency.
See More
